Patents Examined by Samantha M Good
-
Patent number: 11950826Abstract: Catheter apparatuses, systems, and methods for achieving renal neuromodulation by intravascular access are disclosed herein. One aspect of the present technology, for example, is directed to a treatment device having a direct heating element configured to be delivered to a renal blood vessel. The treatment device is selectively transformable between a delivery or low-profile state and a deployed state. The direct heating element is housed within an occlusion element which is sized and shaped so that the direct heating element contacts an interior wall of the occlusion element, an outer wall of which is simultaneously in contact with the inner wall of a renal blood vessel when the treatment assembly is in the deployed state. The direct heating element is configured to apply thermal energy to heat neural fibers that contribute to renal function.Type: GrantFiled: June 24, 2020Date of Patent: April 9, 2024Assignee: Medtronic Ireland Manufacturing Unlimited CompanyInventor: Roman Turovskiy
-
Patent number: 11950832Abstract: Concepts presented herein relate to an interface module that can be electrically coupled to an electrical stimulation generator, a radio frequency generator and an instrument. A selection module is coupled to the interface module and operates in a first mode to deliver electrical stimulation signals from the electrical stimulation generator to the instrument and in a second mode to deliver radio frequency signals from the radio frequency generator to the instrument.Type: GrantFiled: March 22, 2021Date of Patent: April 9, 2024Assignee: MEDTRONIC XOMED, INC.Inventors: Kevin Lee McFarlin, John C. Bruce, David C. Hacker, Robert Allen Tucker
-
Patent number: 11950833Abstract: A method of determining contact status of electrodes includes applying drive signals between pairs of electrodes, measuring a bipolar electrode complex impedance (BECI) value generated in response to the drive signals over a collection period, and determining a baseline BECI value representing a minimum value measured during the collection period. The method further includes determining contact status of the electrode by applying drive signals between pairs of electrodes over a given interval, measuring a BECI value generated in response to the drive signals, measuring a peak-to-peak value associated with the BECI values measured over the given interval, and determining contact status based on a combination of the baseline BECI value, the measured BECI value, and the peak-to-peak value associated with the measured BECI values.Type: GrantFiled: January 12, 2023Date of Patent: April 9, 2024Assignee: St. Jude Medical, Cardiology Division, Inc.Inventors: Eric J. Voth, Jeffrey A. Schweitzer
-
Patent number: 11918270Abstract: An electrosurgical generator supplies, during operation, a high-frequency alternating current to an electrosurgical instrument for plasma cutting of body tissue. The electrosurgical generator has outputs for connecting an electrosurgical instrument to supply an electrosurgical instrument connected to the outputs with a high-frequency alternating current, and for determining the impedance of a load connected to the outputs. The electrosurgical generator features impedance and voltage measuring units as well as an output voltage control unit. The output voltage control unit is designed to control the AC output voltage depending on a maximum output voltage value that is set during operation depending on an output value of the impedance measuring unit and/or depending on an output value of the voltage measuring unit, such that the maximum output voltage value predefines a lower AC output voltage during a vaporization phase than during an ignition phase occurring subsequently to the vaporization phase.Type: GrantFiled: March 29, 2021Date of Patent: March 5, 2024Assignee: OLYMPUS WINTER & IBE GMBHInventors: Jelle Dijkstra, Veronika Handrick, Andreas Karrasch, Frank Breitsprecher
-
Patent number: 11903637Abstract: In one aspect, the present disclosure is directed to methods of treating various conditions including bladder conditions in a patient, comprising: positioning at least one ablative element of an ablative device on or over an adventitial surface of the bladder; and using the ablative device to denervate bladder nerve fibers. Other aspects of the present disclosure pertain, for example, to devices and kits for of treating bladder conditions.Type: GrantFiled: June 2, 2020Date of Patent: February 20, 2024Assignee: BOSTON SCIENTIFIC SCIMED, INC.Inventors: Thomas John Herbst, Mark W. Boden, Sandra Nagale
-
Patent number: 11903630Abstract: An electrosurgical apparatus with a retractable blade for use in cold plasma applications, electrosurgical cutting and mechanical cutting is provided. The electrosurgical apparatus employs a tip of the retractable blade as a sharp conductive point to generate a plasma beam or discharge. When the blade is retracted within the electrosurgical apparatus, it is electrically energized while an inert gas flows over it, producing a cold plasma discharge. In the de-energized state, the blade is advanced and used as a traditional, mechanical surgical blade.Type: GrantFiled: November 23, 2020Date of Patent: February 20, 2024Assignee: Apyx Medical CorporationInventors: Jeffrey C. Rencher, Gregory A. Konesky, Borislav S. Simeonov
-
Patent number: 11896293Abstract: Nasal airway reshaping is accomplished using a fractional treatment device applied externally to the nose to insert needle electrodes into nasal tissue to be reshaped. Energy is applied via the electrodes to cause at least partial coagulation of the nasal tissue within zones around each of the plurality of needle electrodes while pressure is applied internally to achieve the desired reshaping.Type: GrantFiled: September 18, 2020Date of Patent: February 13, 2024Assignee: Inmode Ltd.Inventor: Michael Kreindel
-
Patent number: 11896284Abstract: A catheter and patch electrode system is provided for use with an apparatus, such as an ablation generator, having a 4-wire interface for improved impedance measurement. The 4-wire interface includes a pair of source connectors across which an excitation signal is produced and a pair of sense connector wires across which the impedance is measured. The RF ablation generator may also produce an ablation signal across a source wire and an indifferent return patch electrode. The system further includes a cable that connects the generator to a catheter. The catheter includes a shaft having a proximal end and a distal end, with an ablation tip electrode disposed at the distal end. A source lead is electrically coupled to the tip electrode and extends through the shaft to the proximal end where it is terminated. An optional sense lead is also electrically coupled to the tip electrode and extends through the shaft to the proximal end. The system further includes a source return (e.g.Type: GrantFiled: April 17, 2020Date of Patent: February 13, 2024Assignee: St. Jude Medical, Atrial Fibrillation Division, IncInventors: Stephan P. Miller, Glen H. Kastner, Donald Curtis Deno
-
Patent number: 11890050Abstract: An esophageal ablation system including a positioner, an elongated, flexible shaft extending from the positioner, and a microwave emitter assembly disposed near the distal end of the shaft. The emitter assembly includes one or more microwave antennae and a balloon for spacing the antennae relative to target tissue. The device may have an inner balloon for deploying the antenna. The systems, devices and methods disclosed are useful for treating Barrett's Esophagus, Esophageal Adenocarcinoma, and Squamous Cell Carcinoma.Type: GrantFiled: December 20, 2021Date of Patent: February 6, 2024Assignee: Symple Surgical, Inc.Inventors: Seth Crozier, Sohail Desai, Dan Kasprzyk, Bryce Alexander Igo
-
Patent number: 11883088Abstract: Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.Type: GrantFiled: May 14, 2020Date of Patent: January 30, 2024Assignee: Gyrus ACMI, Inc.Inventors: Kester Julian Batchelor, Wayne Williams
-
Patent number: 11877787Abstract: Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.Type: GrantFiled: May 14, 2020Date of Patent: January 23, 2024Assignee: Gyrus ACMI, Inc.Inventors: Kester Julian Batchelor, Huisun Wang
-
Patent number: 11832870Abstract: Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.Type: GrantFiled: May 14, 2020Date of Patent: December 5, 2023Assignee: Gyrus ACMI, Inc.Inventors: Kester Julian Batchelor, Huisun Wang
-
Patent number: 11832875Abstract: Methods, systems and devices for evaluating the integrity of a uterine cavity. A method comprises introducing transcervically a probe into a patient's uterine cavity, providing a flow of a fluid (e.g., CO2) through the probe into the uterine cavity and monitoring the rate of the flow to characterize the uterine cavity as perforated or non-perforated based on a change in the flow rate.Type: GrantFiled: November 22, 2021Date of Patent: December 5, 2023Assignee: MINERVA SURGICAL, INC.Inventors: Akos Toth, Robin Bek, Dominique Filloux, Tejas N. Mazmudar, Csaba Truckai
-
Patent number: 11819258Abstract: Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.Type: GrantFiled: May 14, 2020Date of Patent: November 21, 2023Assignee: Gyrus ACMI, Inc.Inventors: Kester Julian Batchelor, Huisun Wang
-
Patent number: 11786298Abstract: Disclosed herein is an epidural catheter with an RF generation function. More specifically, the epidural catheter with an RF generation function may include a main body, an inserting part being connected to the main body and being inserted inside a physical body, and a manipulating part being provided in the main body and being connected to the inserting part or an internal assembly part of the inserting part, so as to manipulate the inserting part or to perform a function of the inserting part, wherein two steering wires may be interpolated in the inserting part, the two steering wires being manipulated by the manipulating part so as to allow flexion of the inserting part to be controlled, and wherein, by allowing power status to be turned on/off using the main body as medium, the steering wires may act as electrodes.Type: GrantFiled: July 7, 2020Date of Patent: October 17, 2023Assignee: JUVENUI Co., LTDInventors: Hyun Hong Kim, Jae Suk Sung
-
Patent number: 11766285Abstract: The instant disclosure relates to electrophysiology catheter for tissue ablation. In particular, the instant disclosure relates to a system controller for facilitating an ablation therapy at a cryogenic ablation balloon. In an embodiment, an ablation an ablation catheter system comprising a catheter shaft including proximal and distal ends, a catheter handle coupled to a proximal end of the catheter shaft, a cryogenic ablation ballon coupled to the distal end of the catheter shaft, the ablation ballon configured and arranged to deliver a cryogenic ablation therapy to target tissue, an ablation system controller coupled to the catheter handle.Type: GrantFiled: October 15, 2018Date of Patent: September 26, 2023Assignee: St. Jude Medical, Cardiology Division, Inc.Inventors: Troy T. Tegg, Salo Arias, Derek C. Sutermeister
-
Patent number: 11730534Abstract: A surgical system includes an end effector assembly, a motor assembly, an energy source, and a controller. The controller activates the motor assembly, once it is determined that tissue is present between jaw members of the end effector assembly, to move the jaw members from a spaced-apart position to an approximated position to grasp tissue. The controller further activates the energy source, once tissue is grasped between the jaw members, to supply energy to the jaw members to seal tissue grasped between the jaw members. The controller further activates the motor assembly, once it is determined that tissue sealing is complete, to move the jaw members from the approximated position to the spaced-apart position to release sealed tissue. The system may further be configured to cut tissue once it is determined that tissue sealing is complete but before moving the jaw members to the spaced-apart position.Type: GrantFiled: April 7, 2020Date of Patent: August 22, 2023Assignee: Covidien LPInventor: Jeffrey L. Jensen
-
Patent number: 11723711Abstract: Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.Type: GrantFiled: May 14, 2020Date of Patent: August 15, 2023Assignee: Gyrus ACMI, Inc.Inventors: Kester Julian Batchelor, Maureen D. Busche, Wayne Williams
-
Patent number: 11712320Abstract: A surgical system for providing an improved video image of a surgical site including a system controller that receives and processes video images to determine a video signature corresponding to a condition that interferes with a quality of the video images, with the system controller interacting with a video enhancer to enhance the video images from a video capturing device to automatically control the video enhancer to enhance the video images. The surgical system can also review the video images for a trigger event and automatically begin or stop recording of the video images upon occurrence of the trigger event.Type: GrantFiled: March 21, 2018Date of Patent: August 1, 2023Assignee: Stryker CorporationInventors: Amit Mahadik, Jagadish Venkataraman, Ramanan Paramasivan, Brad Hunter, Afshin Jila, Kundan Krishna, Hannes Rau
-
Patent number: 11701163Abstract: A DC-to-DC voltage regulator circuit comprising: an output node; a pull-up switch and a pull-down switch with an output node coupled between them; a reactive circuit element coupled to the output node; a pull-up setting voltage circuit coupled to provide a pull-up setting voltage that is a function of a voltage at the output node; a pull-down setting voltage circuit coupled to provide a pull-down setting voltage that is a function of the voltage at the output node; a first comparator coupled to cause the pull-up switch to transition between open switch state and its closed switch state based upon a comparison of the pull-up setting voltage and a control voltage; and a second comparator coupled to cause the pull-down switch to transition between its open switch state and its closed switch state.Type: GrantFiled: May 31, 2018Date of Patent: July 18, 2023Assignee: Intuitive Surgical Operations, Inc.Inventor: Duane W. Marion